TotalMarketCap

Yarrow Bioscience

YARWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$126.074 M

$13.55 -9.12%

Close of 6 Nov 2026

As of 6 Nov 2026, Yarrow Bioscience (YARW) has a market capitalization of $126.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$570.0K

#3503 by revenue

Earnings

-$26.5M

Loss-making

Shares outstanding

2,669,746

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #273Jyong BiotechMENS$129.2M
  2. #274Cue BiopharmaCUE$128.9M
  3. #275Yarrow BioscienceYARW$126.1M
  4. #276PDS BiotechnologyPDSB$123.9M
  5. #277Spruce BiosciencesSPRB$122.4M

What if Yarrow Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,034,800

Per share 223,970× higher

Bitcoin $1.53T

$164,207.74

Per share 12,119× higher

Apple $5.02T

$539,078.67

Per share 39,784× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Yarrow Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.